Literature DB >> 7717795

Imported malaria. Clinical presentation and examination of symptomatic travelers.

J E Svenson1, J D MacLean, T W Gyorkos, J Keystone.   

Abstract

BACKGROUND: The diagnosis of malaria in nonendemic countries presents a continuing challenge. Increasing physician awareness of the variability in its clinical presentation will improve clinical management and health outcomes.
METHODS: Charts of patients in whom malaria was diagnosed at two hospital-based tropical disease centers between September 1, 1980, and December 31, 1991, were reviewed.
RESULTS: Of a total of 482 cases, 182 were caused by Plasmodium falciparum and 246 by Plasmodium vivax. Fifty-two patients with P falciparum malaria were hospitalized; 13 were classified as having severe falciparum malaria. Nineteen patients with P vivax malaria required hospitalization. The only death was caused by P vivax. Chemoprophylaxis was used by, or prescribed for, 46% of patients; however, of these, only half were compliant in taking their medication. Eighty-seven percent of patients with falciparum malaria presented within 6 weeks of return from travel to an endemic area. One third of patients with P vivax malaria presented more than 6 months after travel. The average time between onset of symptoms and physician contact was 6.7 days. Diagnosis was often delayed in those who sought care outside the referral center. Almost all patients had a history of fever, but only half were febrile at presentation. Presenting symptoms and signs were non-specific. Fifty percent of patients were thrombocytopenic. Other laboratory abnormalities were mild.
CONCLUSIONS: Since the presentation of malaria is vague and nonspecific, the diagnosis should be considered in any appropriately symptomatic patient with a history of travel to a malaria-endemic area, and appropriate testing should be done. Up-to-date information on chemoprophylaxis should be provided to all travelers to malaria-endemic regions.

Entities:  

Mesh:

Year:  1995        PMID: 7717795     DOI: 10.1001/archinte.155.8.861

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  28 in total

Review 1.  The return of swamp fever: malaria in Canadians.

Authors:  J D MacLean; B J Ward
Journal:  CMAJ       Date:  1999-01-26       Impact factor: 8.262

Review 2.  Evaluating fever in travellers returning from tropical countries.

Authors:  A Humar; J Keystone
Journal:  BMJ       Date:  1996-04-13

3.  Travelers' malaria among foreigners at the Hospital for Tropical Diseases, Bangkok, Thailand - a 6-year review (2000-2005).

Authors:  Watcharapong Piyaphanee; Srivicha Krudsood; Udomsak Silachamroon; Karnchana Pornpininworakij; Phatcharee Danwiwatdecha; Supat Chamnachanan; Polrat Wilairatana; Sornchai Looareesuwan
Journal:  Korean J Parasitol       Date:  2006-09       Impact factor: 1.341

4.  Splenomegaly in 2,505 patients in a large university medical center from 1913 to 1995. 1913 to 1962: 2,056 patients.

Authors:  R A O'Reilly
Journal:  West J Med       Date:  1998-08

Review 5.  Transition-state inhibitors of purine salvage and other prospective enzyme targets in malaria.

Authors:  Rodrigo G Ducati; Hilda A Namanja-Magliano; Vern L Schramm
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

6.  Malaria "epidemic" in Quebec: diagnosis and response to imported malaria.

Authors:  Momar Ndao; Etienne Bandyayera; Evelyne Kokoskin; David Diemert; Theresa W Gyorkos; J Dick MacLean; Ron St John; Brian J Ward
Journal:  CMAJ       Date:  2005-01-04       Impact factor: 8.262

7.  Selective ambulatory management of imported falciparum malaria: a 5-year prospective study.

Authors:  E Bottieau; J Clerinx; R Colebunders; E Van den Enden; R Wouters; H Demey; M Van Esbroeck; T Vervoort; A Van Gompel; J Van den Ende
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-03       Impact factor: 3.267

Review 8.  Malaria.

Authors:  Kathryn N Suh; Kevin C Kain; Jay S Keystone
Journal:  CMAJ       Date:  2004-05-25       Impact factor: 8.262

9.  Special Challenges in the Prevention and Treatment of Malaria in Children.

Authors:  William M. Stauffer; Deepak Kamat
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

10.  Prevalence and association of malaria with ABO blood group and hemoglobin level in individuals visiting Mekaneeyesus Primary Hospital, Estie District, northwest Ethiopia: a cross-sectional study.

Authors:  Belaynesh Tazebew; Abaineh Munshea; Endalkachew Nibret
Journal:  Parasitol Res       Date:  2021-03-03       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.